Reducing the Unexpected and Unnecessary Costs of Musculoskeletal Condition Care
Musculoskeletal (MSK) injuries or disorders affect nearly half of U.S. adults1 and are one of the top health categories of plan sponsor spend at $420B. This topic was the focus of a breakout sessi...
Read MoreUncovering behind-the-scenes challenges in bringing gene therapies to market
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Read MoreStrategies to Encourage the Adoption of Biosimilars
Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.
Read MoreEvernorth employees provide outstanding health care services to customers and patients
Get to know the Evernorth employees who are working hard to provide excellent health care services to members.
Read MoreSpecialty Drug Fraud, Waste and Abuse Prevention
By leveraging automation as the linchpin of a comprehensive plan to mitigate fraud, waste and abuse, plan sponsors can help drive significantly lower specialty drug spending.
Read MoreClinically Speaking: Behavioral Health Services in America
92% of adults living with a behavioral health condition also struggle with a physical condition, costing billions annually. We detail strategies to overcome the barriers that keep individuals from see...
Read MoreUnderstanding Hemophilia
Breaking down the challenges, therapies and costs associated with hemophilia.
Read More